Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Human Longevity Inc, Medical Devices Deals, 2012 to YTD 2018 10
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Human Longevity Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 12
Venture Financing 13
Celularity Raises USD250 Million in Venture Financing 13
Celularity Raises Funds through Series A Financing 15
Human Longevity Raises US$70 Million In Venture Financing 16
Partnerships 17
Sorrento Therapeutics, Celgene, United Therapeutics and Human Longevity Form Joint Venture 17
Human Longevity Enters into Agreement with Merck 19
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 20
Cypher Genomics Enters into Co-Development Agreement with Celgene 21
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 22
Licensing Agreements 23
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 23
Acquisition 24
Human Longevity Acquires LifebankUSA from Celgene Cellular Therapeutics 24
Human Longevity Inc – Key Competitors 25
Human Longevity Inc – Key Employees 26
Human Longevity Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Jul 13, 2018: Human Longevity Appoints Dr. David Karow, MD, Ph.D., As Interim Chief Executive Officer 28
Mar 19, 2018: Human Longevity, Inc. Hires Former Ancestry Executive, Scott Sorensen, As New Chief Technology Officer 29
Dec 01, 2017: Human Longevity Announces Executive Leadership Changes: Co-Founder J. Craig Venter, Ph.D. is Reappointed as CEO 30
May 25, 2017: Saturnino Fanlo Joins Human Longevity As Chief Financial Officer 31
May 02, 2017: Human Longevity Enhances Senior Leadership Team, Making Key Hires to Strengthen Commercialization and Operations 32
Jan 04, 2017: Human Longevity Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer 34
Legal and Regulatory 36
Apr 18, 2018: Human Longevity Clinical Labs Receives Accreditation from College of American Pathologists 36
Government and Public Interest 37
Feb 26, 2018: Human Longevity Scientists Publish Paper Diving Deeper into Non-Coding Genome Which Represents 98% of the Human Genome 37
Feb 05, 2018: New Metabolomic and Genomic-Informed Study Shows Use of Acetaminophen Has Unexpected Effects on Regulation of Sex Hormones 38
Product News 39
Aug 21, 2017: Celularity Accelerates Breakthrough Placental Discovery & Therapeutic Platform 39
Jul 03, 2017: Human Longevity Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology 40
Mar 28, 2018: Human Longevity Launches New Health Nucleus Products With Membership Component 41
Mar 06, 2017: In Largest Whole Genome Sequence Analysis Study, Human Longevity-Led Team Identifies Common-to-Rare Variants in the Human Blood Metabolome 42
Other Significant Developments 43
May 11, 2017: Human Longevity, Inc. Launches Pilot Program, Health Nucleus X 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Human Longevity Inc, Pharmaceuticals & Healthcare, Key Facts 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Human Longevity Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Human Longevity Inc, Medical Devices Deals, 2012 to YTD 2018 10
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 12
Celularity Raises USD250 Million in Venture Financing 13
Celularity Raises Funds through Series A Financing 15
Human Longevity Raises US$70 Million In Venture Financing 16
Sorrento Therapeutics, Celgene, United Therapeutics and Human Longevity Form Joint Venture 17
Human Longevity Enters into Agreement with Merck 19
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 20
Cypher Genomics Enters into Co-Development Agreement with Celgene 21
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 22
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 23
Human Longevity Acquires LifebankUSA from Celgene Cellular Therapeutics 24
Human Longevity Inc, Key Competitors 25
Human Longevity Inc, Key Employees 26
Human Longevity Inc, Other Locations 27
Human Longevity Inc, Subsidiaries 27
List of Figures
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Human Longevity Inc, Medical Devices Deals, 2012 to YTD 2018 10